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Abstract
Aims: The aim of this study was to determine the effects DynaCleft® has on patients with bilateral cleft lip and palate. Subjects
and Methods: Comparative data were collected from a total of 46 infants diagnosed with bilateral cleft lip and palate between
1981 and 2017. Twenty-three infants were treated with DynaCleft® and an obturator and 23 infants received an obturator only.
Maxillary  impressions were taken at  each infant's  initial  clinic visit  and again on the day of  his/her  surgical  cleft  lip  repair.
Differences in maxillary retraction, sagittal repositioning, and cleft widths were compared between the two groups. Statistical
Analysis Used: Paired t-tests were used to determine if there was significant change before and after DynaCleft® therapy, and
two-sample t-tests were used to compare the data between the two study groups. Results: Clinically, DynaCleft® averaged more
maxillary retraction and cleft size reduction on both the right and left sides compared to the control group. Within the DynaCleft®
group, a statistically significant difference was found for premaxillary retraction on both the right and left sides. However, all the
other  comparisons  between  the  two  groups  were  not  found  to  be  statistically  significant.  Conclusions:  DynaCleft®  as  a
presurgical orthopedic therapy may help to limit uncontrolled physiological changes and reposition the premaxillary segment,
while reducing cleft widths prior to definitive lip surgery.
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Craniofacial anomalies are a diverse group of congenital head-and-neck abnormalities, with the most common being a cleft lip,
palate, or both, which can present as a unilateral or bilateral occurrence. In the United States, 1 in every 940 newborns is born
with a cleft lip or palate, totaling over 4400 cases annually.[1] A bilateral cleft lip and palate is the least common form of the
abnormality, resulting in only 0.3 of 1000 live births,[2] but it is one of the most challenging forms to treat due to a deficient
columella and repositioning of the premaxillary segment in relation to the two clefts.[3] Treatment of the cleft lip and/or palate
requires a team of dental and medical specialists, and starts as early as the first few months of life and continues through
adulthood.[4] Comprehensive treatment for patients with bilateral cleft lip and palate typically consists of presurgical orthopedic
(PSO) treatment and multiple surgeries throughout their lifetime, with continued postsurgery care by a pediatric and/or general
dentist.[3]  Patients with bilateral cleft  lip and palate require a long-term commitment from the family and expenses that can
exceed $100,000.[5]
PSO treatment involves the active movement of  the maxillary  segments with passive or  active alveolar  appliances prior to
surgical repair.[6] The main goals of PSO are helping with intraoral feeding, improving maxillary growth, improving the projection
of the nasal tip, reducing the nasal deformity, an adjunct in the primary lip, nasal, and alveolar surgeries, and retracting and
repositioning the premaxilla more posteriorly and centrally located in patients with bilateral clefts.[6] In general, there are multiple
clinical aspects that determine whether a patient needs PSO prior to surgery, and if so, what type should be used. Whether the
cleft is complete, does the patient have feeding issues, and is the premaxilla protruded or off center are all aspects that should be
considered.
The nasoalveolar molding (NAM) appliance, one method of presurgical therapy, helps to reduce the cleft  size, correct nasal
deformities and asymmetries, and lengthen the columella prior to the patient's first lip surgery. These attributes lead to a more
esthetic and successful cleft repair outcome. However, because the NAM is a custom appliance, it requires multiple adjustments
as the treatment  progresses and the infant  grows.  Bilateral  cleft  lip  and  palate  patients  wearing  the NAM appliance as  a
presurgical treatment may need up to twenty additional in-office visits prior to the initial lip surgery,[5] which may increase the
time and financial burden for these families.
Lip adhesion surgery is another form of PSO undertaken prior to definitive lip closure. Lip adhesion is a surgical intervention that
helps approximate the cleft segments and idealize nose position prior to final lip closure, requiring lip surgery to become a two-
step process.[7] This additional procedure reconstructs a complete cleft into an incomplete cleft, which, in bilateral cleft patients,
can help to control the protrusive premaxilla prior to definitive lip surgery. Although there are benefits to this procedure, it does
require undergoing additional general anesthesia and there is an increased risk of lip dehiscence and scar tissue formation.[7]
DynaCleft® [Figure 1] is a premade adhesive device worn prior to cleft lip repair. It is a PSO with an elastomeric center which
applies constant approximation forces that help mold the bone and soft tissues surrounding the clefts, as well as, create more
nasal symmetry.[8] In cases of bilateral cleft patients, where the premaxillary segment between the two clefts can be significantly
malpositioned, wearing DynaCleft® prior to lip surgery helps to reposition the segment. This can improve surgical results and
decrease the need for lip adhesion surgery.[8] Unlike the NAM appliance, DynaCleft® does not require adjustments with growth
of the infant,[8] which reduces the frequency of office visits and additional costs.[5]{Figure 1}
The purpose of this study was to determine the presurgical effects DynaCleft® has on patients with complete bilateral cleft lip and
palate.
This retrospective study was conducted at the craniofacial center of a metropolitan children's hospital and was approved by the
institutional  review  board  as  study  #1111007344.  DynaCleft®  was  introduced  and  utilized  as  the  standard  of  care  at  our
craniofacial  center  for  complete  unilateral  and bilateral  cleft  patients  in  January 2010. Data were collected from 46 infants
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diagnosed with bilateral complete cleft lip and palate. The 46 patients were split into two groups of 23: one group was treated with
DynaCleft® and the other was the control group who did not receive DynaCleft® therapy. All  patients had maxillary alginate
impressions taken at their initial presentation to clinic and then again on the day of their cleft lip repair. All the impressions were
poured in dental stone. The treatment group received their DynaCleft® appliance at their initial appointment in the craniofacial
clinic after being carefully evaluated by the craniofacial team which includes plastic and oral surgeons, as well as a pediatric
dentist. After deemed an appropriate candidate for the therapy, the craniofacial clinic disperses the therapy at no cost to the
patient via a grant from the Women for Riley/Riley Children's Foundation. A comprehensive demonstration on how to place the
appliance and printed instructions for care were provided to all patients' caregivers. The control group patients were treated in the
craniofacial clinic prior to the initiation of DynaCleft® therapy. All 46 patients had their initial impression taken around 1 month of
age.
A predetermined set of points on the casts were used to measure the physiological changes that occurred between the two
impressions for both groups: the right tuberosity (RT), left tuberosity (LT), incisal point (I), right alveolar crest (RA), left alveolar
crest (LA), and the right premaxillary (RP) and left premaxillary (LP) segment points [Figure 2].[8]{Figure 2}
Dental casts for both groups were measured twice by the same individual with a Carrera Precision digital caliper (Max Tool LLC,
LaVerne  CA,  USA)  to  ensure  repeatability,  and  then  the  measurements  were  averaged  and  loaded  into  an  Excel  file.
Intersegment distances were measured using the tuberosity and canine points. Intercleft distances were measured between the
corresponding cleft side's premaxillary segment point and alveolar crest point as indicated by the RP-RA or LP-LA measurement.
In addition, retraction of the premaxillary segment was determined by measuring the distance between the RT and LT and each
premaxillary segment as indicated by RP-RT and LP-LT. Paired t-tests were used to determine if there was significant change
before and after DynaCleft® therapy, and two-sample t-tests were used to compare the data between the two study groups.
The DynaCleft® group had their first impression taken on an average at 19.4 days of age, with their follow-up impression taken
on an average of 127.8 days later. The control group's first impression was taken on an average at 36.7 days of age, while their
follow-up  impression  averaged  107.8  days  later.  Utilization  of  intraclass  correlation  coefficients  and  Bland–Altman  plots
determined all measurements to have excellent repeatability. No changes from initial visit to follow-up were significantly different
between DynaCleft® and control groups [Table 1].{Table 1}
This study was an attempt to assess the physiological effects of DynaCleft® on bilateral complete cleft lip and palate patients. In
bilateral cleft lip and palate patients, the premaxillary segment that is separated by two clefts is usually not central and can
protrude forward. DynaCleft®'s constant approximation forces pull the premaxillary segment back to a more anatomically correct
location prior to surgery, which helps to centrally position the premaxilla and reduce cleft widths [Figure 3]. Although the data
found no statistical significance between the two treatment groups for presurgical management of bilateral cleft lip and palates,
they demonstrated that wearing DynaCleft® has clinical significance in restricting forward position and retracting the premaxillary
segment,  as  well  as  reducing  cleft  sizes  more  so  than  the  control  group.  The  average  changes  from initial  to  follow-up
measurements for the DynaCleft® group appear to be small, but with craniofacial surgeries, millimeters may affect the outcome
and perhaps result in a more esthetic outcome. DynaCleft® can be utilized as a method of PSO therapy for bilateral cleft patients
due to its ability to centralize and restrict forward displacement of the premaxillary segment and reduce cleft sizes, creating a
more anatomically correct relationship for future cleft lip repair surgery.{Figure 3}
PSOs are widely used among craniofacial teams throughout the world. Critics believe that the added cost and increased office
visits of these therapies do not outweigh the benefit they provide. They believe that the short-term effects do not significantly
impact the long-term outcome of  the cleft  repair.[6]  Garfinkle et  al.  found no difference between bilateral  cleft  patients who
received PSOs and their noncleft, age-matched control group at 12 years of age.[9]
However, many craniofacial teams continue to use PSOs as an adjunct for treatment of cleft lip and palates. DynaCleft® is just
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one of the several PSO options for families who lack the time and resources required for the NAM appliance or want to avoid
additional anesthesia required for lip adhesion surgery. Without additional office visits, DynaCleft® provides the infant the benefits
of prevention of forward growth and retraction of the premaxilla, as well as reducing cleft sizes prior to definitive lip surgery. Due
to its elastomeric core and stretch property, DynaCleft® allows the infant to feed and cry without limitation. It also does not need
to be remade or adjusted for infant growth like the NAM appliance.
There were some limiting factors to this study. At the initial delivery of DynaCleft®, the caregivers were demonstrated its proper
placement and thoroughly explained when to replace each strip. The providers had to rely on the compliance of the caregivers to
follow the provided instructions. Because our results are based on each patient's caregiver placing the therapy, this leads to
increased variability. Other limitations to the study were the small sample size and the inability to control when each patient had
their initial clinic visit and their surgical repair which would impact the results as each patient's DynaCleft® use period was not
consistent.
The results of this study demonstrate that utilizing DynaCleft® as a method of PSO therapy may help limit anterior position and
potentially centralize the clefted premaxillary segment to a more ideal location prior to surgery. Decreases in cleft widths were
found among the bilateral cleft lip and palate patients who used DynaCleft®. The clinical attributes DynaCleft® provides are
beneficial for craniofacial teams who choose to utilize PSOs for bilateral cleft lip and palate patients as part of their routine
treatment plan.
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